Atlantis Healthcare’s new NZ Managing Director To Drive Patient-Centred Innovation
Atlantis Healthcare, a leading provider of patient support solutions globally, announced this week that a new Managing
Director has been appointed in New Zealand; Kate Reid will take the reins from current Acting Managing Director and
Chief Financial Officer, Tony Wai early next year.
Kate Reid, the current Managing Director of Atlantis Healthcare in the United Kingdom, accepted this role after electing
to leave London after fourteen years to return to her roots in New Zealand.
“Kate has been instrumental in the success of Atlantis Healthcare in Europe; under her leadership the UK business has
grown to be a leading provider of patient adherence and behaviour change solutions for Europe’s largest pharmaceutical
businesses,” says Atlantis Healthcare’s Chief Executive Officer, Aunia Grogan.
“The New Zealand Atlantis business has recently been through an exciting period of growth, where the focus has been on
supporting the industry to improve adherence to treatment and developing patient-centred solutions to achieve this,” explains Tony Wai, the current Acting Managing Director of
Atlantis in New Zealand.
“I have thoroughly enjoyed the opportunity to lead such a talented team through this period, and the time is now right
for new leadership to continue the momentum going forward,” says Tony.
“I am very excited to be taking up this new and challenging role with Atlantis in New Zealand, where adherence and
patient-centred care is a key focus for the healthcare system,” says Kate Reid.
Atlantis Healthcare originally launched in New Zealand in 1993 as an innovative healthcare data and relationship
marketing services business. Today the business has a global reach with offices in New Zealand, Australia, Germany,
Spain, the United Kingdom and United States.
With one of the world’s largest Health Psychology clinical teams governed by some of the industry’s leading academics,
Atlantis Healthcare has supported well over 750,000 patients, empowering them to take medication as prescribed and
better self-manage their chronic conditions throughout and beyond their treatment journey.
------
Tony Wai
Chief Financial Officer, Atlantis Healthcare Group
An experienced business manager and a fully qualified accountant (holding both NZ and UK professional accountancy
qualifications) he is the CFO of Atlantis Healthcare Group. Tony Wai has worked in senior finance roles in some of New
Zealand’s largest companies and has also run a number of successful start-ups and high growth companies. He brings a
strong commercial focus to the company and has an intimate knowledge of the Healthcare services space from a business
perspective.
Kate Reid
Managing Director – United Kingdom (current)
Managing Director – New Zealand (Commencing January 2013)
Prior to joining Atlantis Healthcare in 2008, Kate spent over eight years working for Roche Products Ltd. working on the
world’s first DTC and patient support program launch for Xenical for weight management as well as gaining experience in
Public Relations, DAC campaigns, CRM programs and Public Affairs & Government liaison. More recently, Kate spent four years at DDB Health Advertising where she worked in Strategic
Planning and Business Director roles supporting brands in different therapy areas (Respiratory, Diabetes, Ophthalmology,
Oncology, Hep C, CV and Neurology).
Atlantis Healthcare:
15+ years of designing and delivering innovative, award-winning patient support programmes
Implemented 80+ programmes across the globe
750,000+ patients supported in programmes developed and implemented by Atlantis Healthcare
winner of 8 global patient communication awards
experience in over 51 disease states spanning different cultures and markets
evidence based approach informed by one of the world’s largest Health Psychology clinical teams, governed by the
industry’s leading academics
partnerships with the world’s leading pharmaceutical companies
offices in Europe, the United Kingdom, United States and Australasia
sponsoring academic research to understand people’s attitudes towards illness, health, and treatment regimens so
that our programmes can effectively drive behavioural change and deliver improved population health outcomes
ENDs